StockData
CNS Pharmaceuticals, Inc. logo

CNS Pharmaceuticals, Inc. (CNSP) stock

CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$4.15+0.67 (+19.25%)

Close on Nov 17, 2026Market cap $6.07MP/E –Yield –

CNS Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

CNS Pharmaceuticals's total assets was $21.94M at Jun 30, 2026. For fiscal 2025 it was $8.62M, down 0.9% from the year before. The highest annual figure on record is $15.85M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.62M-0.9%
FY2024Dec 31, 2024$8.70M+411.6%
FY2023Dec 31, 2023$1.70M-87.0%
FY2022Dec 31, 2022$13.05M+49.1%
FY2021Dec 31, 2021$8.76M-44.8%
FY2020Dec 31, 2020$15.85M+100.4%
FY2019Dec 31, 2019$7.91M+1057.9%
FY2018Dec 31, 2018$683.33K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$21.94M+51.2%
Q1 FY2026Mar 31, 2026$4.65M-66.2%
Q4 FY2025Dec 31, 2025$8.62M-0.9%
Q3 FY2025Sep 30, 2025$11.87M+60.2%
Q2 FY2025Jun 30, 2025$14.51M+487.5%
Q1 FY2025Mar 31, 2025$13.75M+727.8%
Q4 FY2024Dec 31, 2024$8.70M+411.6%
Q3 FY2024Sep 30, 2024$7.41M+218.3%
Q2 FY2024Jun 30, 2024$2.47M-61.7%
Q1 FY2024Mar 31, 2024$1.66M-77.6%
Q4 FY2023Dec 31, 2023$1.70M-87.0%
Q3 FY2023Sep 30, 2023$2.33M-75.8%
Q2 FY2023Jun 30, 2023$6.45M-48.2%
Q1 FY2023Mar 31, 2023$7.41M-53.3%
Q4 FY2022Dec 31, 2022$13.05M+49.1%
Q3 FY2022Sep 30, 2022$9.64M-16.2%
Q2 FY2022Jun 30, 2022$12.45M-12.6%
Q1 FY2022Mar 31, 2022$15.87M+20.7%
Q4 FY2021Dec 31, 2021$8.76M-44.8%
Q3 FY2021Sep 30, 2021$11.51M+285.5%
Q2 FY2021Jun 30, 2021$14.24M+257.2%
Q1 FY2021Mar 31, 2021$13.14M+111.6%
Q4 FY2020Dec 31, 2020$15.85M+100.4%
Q3 FY2020Sep 30, 2020$2.99M+113.6%
Q2 FY2020Jun 30, 2020$3.99M+483.3%
Q1 FY2020Mar 31, 2020$6.21M–
Q4 FY2019Dec 31, 2019$7.91M–
Q3 FY2019Sep 30, 2019$1.40M–
Q4 FY2018Dec 31, 2018$683.33K–

More CNS Pharmaceuticals figures

See a number that looks wrong?